Navigation Links
Medasense Receives Patent Approval for Novel Pain-Monitoring System
Date:8/20/2013

Tel Aviv, Israel (PRWEB) August 20, 2013

Medasense Biometrics Ltd. announced today it has received U.S. patent approval for its novel system and multi-parameter method of assessing the pain level of patients in various states of consciousness. (U.S. Patent No. 8,512,240 – “System and Method for Pain Monitoring Using a Multidimensional Analysis of Physiological Signals.”)

Medasense’s innovative technology enables non-invasive, objective, pain monitoring by measuring multiple pain-related physiological parameters. The data is then integrated using state-of-the-art signal processing and pattern recognition algorithms to identify a patient’s unique “signature of pain.” Using this information, physicians can adapt pain medications to patient-specific needs to reduce suffering and improve treatment outcomes.

“Pain is now widely considered the fifth vital sign,” says Galit Zuckerman, founder and CEO of Medasense. “Our easy-to-use system adds objective pain measurement to the array of technically advanced patient-monitoring tools already used in critical care, anesthesia and recovery, and similar environments.”

Medasense’s successfully completed clinical studies verify the system’s ability to accurately measure pain response and demonstrate that it outperforms all existing pain indicators. “Receiving this patent approval is a milestone achievement for the Medasense team,” says Zuckerman. “We look forward to providing physicians with a much better way to monitor and manage patient pain.”

About Medasense
Medasense Biometrics Ltd. is an early-stage medical device company specializing in innovative pain monitoring solutions. The company’s automated pain-monitoring system is designed to provide a continuous, highly accurate assessment of a patient’s pain level. Medasense is financed and supported by both private investors and by Medoc Ltd., a prominent manufacturer of pain diagnostic medical systems. For more information, visit: http://www.medasense.com/.

CONTACT:
Nir Ben Israel
Medasense Biometric Ltd.
info(at)medasense(dot)com
Tel. 972-4-9038800

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038757.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UCSB professor receives award for graphene electronics research
2. Watsons Generic Yaz(R) Receives FDA Approval
3. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
6. Intimate Bridge 2 Conception, Inc. Receives $4.3M
7. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
8. BioNeutral Group Receives $400,000 in Equity Financing
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... DES MOINES, Iowa , Feb. 22, 2017 Origin ... an agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and ... of a key corn biotechnology product developed in China ... completion of global regulatory trials. ...
(Date:2/22/2017)... ROCHELLE, VIRGINIA (PRWEB) , ... February 22, 2017 ... ... announced today that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in ... in CDER’s Pilot Drug Evaluation Staff has joined the company as an Expert ...
(Date:2/22/2017)... and SAN DIEGO , ... (the "Company") (OTCQB:CELZ) announced today expansion of its ... stem cell product through establishment of laboratory facilities ... activities at the San Diego BioLabs facility, a ... Ingelheim, Novartis, and Sanofi. In November ...
(Date:2/21/2017)... ROCKVILLE, Md. , Feb. 21, 2017 Synthetic ... therapeutics designed to preserve the microbiome to protect and restore the ... for the year ended December 31, 2016 on Thursday, March 2, ... 4:30 p.m. EST. The dial-in information for the call is as ... ...
Breaking Biology Technology:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
Breaking Biology News(10 mins):